CancerVax Achieves Major Milestones and Files Foundational Patent Application
The Company filed a substantial non-provisional PCT patent application seeking worldwide protection for its novel cancer treatment platform […]
Category: BioUtah News
Epic Ventures Gains $200M Fresh Capital
Epic Ventures Gains $200M Fresh Capital […]
CivicaScript® launches low-cost treatment to improve walking for people with multiple sclerosis
CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, today announced the availability of generic dalfampridine extended release tablets. Dalfampridine is a potassium channel blocker indicated to improve walking in certain adult patients with multiple sclerosis (MS). Specific information about the use of dalfampridine can be found here. CivicaScript will […]
HUNTSMAN MENTAL HEALTH INSTITUTE CELEBRATES 10 YEARS OF BEHAVIORAL HEALTH INTEGRATION PROGRAM
The groundbreaking care model expanded from 5 to 15+ clinic locations to achieve 15% patient penetration rate, exceeding national benchmarks SALT LAKE CITY, UT — August 12, 2025 – Huntsman Mental Health Institute at the University of Utah is celebrating the 10th anniversary of its groundbreaking Behavioral Health Integration (BHI) Program, which has transformed mental […]
SINTX Technologies Issues Business Update Following Strategic Realignment, Leadership Expansion, and SiNAPTIC Acquisition
SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in silicon nitride (Si₃N₄) for medical device applications, today issued a business update in connection with the filing of the Company’s Quarterly Report on Form 10-Q for the period ended June […]
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE). The first WRAP North America patient was enrolled at Bluff City Vascular, an interventional nephrology and vascular access center in Memphis, TN. SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) — […]
Shedding Light On Cardiac Repair: How Red-Light Preconditioning Improves Cell Therapy
Following a heart attack, fibrosis is the primary obstacle to recovery. Healthy heart muscle is replaced with non-functional scar tissue, which stiffens the heart wall and leads to chronic heart failure. While therapies have been investigated, cell-based therapies have failed to resolve this issue, as transplanted cells do not survive or engraft effectively in the […]
Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand
Certification underscores Owlet’s commitment to bringing medically-certified infant monitoring technology to every family across the globe. LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia’s Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices […]
bioMérieux receives U.S. FDA 510(k) clearance and CLIA-waiver for Anterior Nasal Swab specimens, an additional sample type for use with the BIOFIRE® SPOTFIRE® R/ST Panel Mini
Marcy-l’Étoile (France), August 18, 2025 – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel Mini has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for the addition of Anterior Nasal Swab (ANS) as a […]
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
WEST VALLEY CITY, Utah – Aug. 21, 2025 – Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope production facility. The site will be capable of producing more than 40 different radioisotopes for use in cancer diagnostics and therapeutics, as well as industrial applications, such as long-lived […]
Sethera Therapeutics Unveils Breakthrough Enzymatic Platform for Next-Generation Peptide Drugs
SALT LAKE CITY, Utah August 21, 2025 — Sethera Therapeutics today announced publication in the Proceedings of the National Academy of Sciences (PNAS) of peer-reviewed results describing an enzymatic crosslinking platform that forges durable thioether “staples,” locking peptides into drug-like cyclic architectures. The platform works across a broad range of substrates, including sequences built entirely […]